On December 11-12 the 1st Immunotherapies for Infectious Diseases (I4ID) Congress will be held in Lyon, France.
Our CEO, Menzo Havenga will participate at the round table “Cross Talk: Challenges for access to immunotherapies in emerging countries”. He will bring to the table his expertise in the proteins, antibodies and vaccines field. Batavia Biosciences is actively involved in a number of Global Health projects aiming to complete preclinical phases at higher speed, with reduced costs and increased success.
The topics covered during the I4ID meeting are: Immunotherapy against viral infections, as alternative treatment to antibiotics, against emergent or re-emergent and bioterrorism agents, Next-Generation Immunotherapy against Infectious Diseases, Cross-talk to accelerate the development and bioproduction of affordable immunotherapy solutions, with the purpose to foster interactions between pharm, research labs, service providers, technology developers, and policy makers.